Stocks of Lilly(Eli) & Co (NYSE:LLY) traded higher last session on Wall Street, up 0.25% to $746.74.
LLY stock price is now -4.93% away from the 50-day moving average and -11.05% away from the 200-day moving average. The market capitalization of the company currently stands at $708.89B.
On November 15, 2024, Wolfe Research recently initiated its ‘Outperform’ rating on the stock quoting a target price of $1000, while ‘Bernstein’ rates the stock as ‘Outperform’
In other news, Zakrowski Donald A, Officer bought 900 shares of the company’s stock on Nov 08 ’24. The stock was bought for $723,042 at an average price of $803.38. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 08 ’24, SVP, Finance, & CAO Zakrowski Donald A sold 900 shares of the business’s stock. A total of $723,042 was realized by selling the stock at an average price of $803.38. This leaves the insider owning 5,480 shares of the company worth $4.09 million. A total of 10.39% of the company’s stock is owned by insiders.
During the past 12 months, Lilly(Eli) & Co has had a low of $612.70 and a high of $972.53. As of last week, the company has a debt-to-equity ratio of 2.19, a current ratio of 1.27, and a quick ratio of 0.97. According to the stock market information, the enterprise value for the company is $699348025344, which is based on a 81.69 price-to-earnings ratio, a 2.48 price-to-earnings-growth ratio, and a beta of 0.42. The fifty day moving average price for LLY is $787.091 and a two-hundred day moving average price translates $839.66144 for the stock.
The latest earnings results from Lilly(Eli) & Co (NYSE: LLY) was released for 2024-09-30. The net profit margin was 20.48% and return on equity was 65.75% for LLY. The company reported revenue of $11.44 billion for the quarter, compared to $9.5 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 20.43 percent. For the current quarter, analysts expect LLY to generate $13.73B in revenue.